The US FTC approves modifications to a divestiture agreement of a medical device company following a merger with a pharmaceutical supplier (Boston Scientific / BTG)

FTC Approves Modifications to Boston Scientific Corp. Divestiture Agreement* The Federal Trade Commission has approved certain modifications to medical device company Boston Scientific Corp.’s Divestiture Agreements. The FTC approved these agreements and

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.